cancer

In the near future, physicians may treat some cancer patients with personalized vaccines that spur their immune systems to attack malignant tumors. New research led by scientists at the School of Medicine including senior author Robert Schreiber, PhD, has brought the approach one step closer to reality.

Lihong Wang, PhD, the Gene K. Beare Distinguished Professor of Biomedical Engineering at the School of Engineering & Applied Science is applying a novel time-reversal technology that allows researchers to better focus light in tissue, such as muscles and organs. ​

Washington University’s Integrating Communication within the Cancer Environment Institute is accepting applications for pilot research projects. Proposals are due 4 p.m. Dec. 19.

New research at the School of Medicine helps explain why brain tumors occur more often in males and frequently are more harmful than similar tumors in females. Pictured is the study’s senior author, Joshua Rubin, MD, PhD.

Arnold Bullock, MD, is highly regarded for his expertise in urology and his community outreach efforts, which are helping to reduce cancer disparities. He has been named the inaugural Alan A. and Edith L. Wolff Distinguished Professor of Urology at the School of Medicine.

New research from the School of Medicine raises the prospect that some cancer patients with aggressive tumors may benefit from a class of anti-inflammatory drugs currently in use against rheumatoid arthritis.

A new center at the School of Medicine will help scientists use the power of the immune system to fight infections and cancers. The Center for Human Immunology and Immunotherapy Programs is part of BioMed21, Washington University’s initiative to accelerate basic science discoveries into improved diagnosis and treatment for patients.

School of Medicine scientists have uncovered a new way the immune system may fight cancers and viral infections. The finding could aid efforts to use immune cells to treat illness.

​Graham Colditz, MD, DrPH, a disease-prevention expert at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, will receive the 2014 American Society of Clinical Oncology (ASCO)–American Cancer Society Award.​

​John DiPersio, MD, PhD, chief of the Division of Oncology at Washington University School of Medicine in St. Louis, and Robert Schreiber, PhD, director of the school’s Center for Human Immunology and Immunotherapy Programs, will be honored in April by the American Association for Cancer Research.